FLUID RETENTION

Adverse reaction reported in 33,525 FDA reports across 20 drugs.

33,525
Total Reports
20
Drugs Involved
Ambrisentan
Most Reported Drug

Drugs Associated with FLUID RETENTION

Drugs where "FLUID RETENTION" was reported as an adverse event.

# Drug Reports % of Total
1 Ambrisentan 5,450
16.3%
2 Treprostinil 5,022
15.0%
3 Macitentan 3,808
11.4%
4 Tadalafil 3,171
9.5%
5 Sacubitril / Valsartan 2,259
6.7%
6 Sildenafil 1,958
5.8%
7 Riociguat 1,743
5.2%
8 Bosentan 1,434
4.3%
9 Oxygen 1,317
3.9%
10 0xygen 1,317
3.9%
11 Selexipag 1,306
3.9%
12 Epoprostenol 924
2.8%
13 Bumetanide 753
2.2%
14 Dasatinib 653
1.9%
15 Standardized Senna 575
1.7%
16 Ketoprofen 530
1.6%
17 Metolazone 494
1.5%
18 Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride 459
1.4%
19 Tafamidis 230
0.7%
20 Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride 122
0.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused fluid retention. Always consult your healthcare provider.